share_log

MAI Capital Management Raises Stock Holdings in Agilent Technologies, Inc. (NYSE:A)

MAI Capital Management Raises Stock Holdings in Agilent Technologies, Inc. (NYSE:A)

Mai资本管理公司增持安捷伦技术公司股票(纽约证券交易所代码:A)
Defense World ·  2022/10/02 06:51

MAI Capital Management lifted its holdings in shares of Agilent Technologies, Inc. (NYSE:A – Get Rating) by 5.1% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,800 shares of the medical research company's stock after acquiring an additional 183 shares during the quarter. MAI Capital Management's holdings in Agilent Technologies were worth $451,000 at the end of the most recent quarter.

根据Mai Capital Management向美国证券交易委员会(Securities And Exchange Commission)的最新披露,该公司在第二季度增持了安捷伦科技公司(Agilent Technologies,Inc.)的股票5.1%。该基金在本季度增持了183股后,持有这家医学研究公司的3,800股股票。在最近一个季度末,Mai Capital Management持有的安捷伦科技股份价值451,000美元。

A number of other institutional investors and hedge funds also recently modified their holdings of the business. Bridgewater Associates LP increased its position in Agilent Technologies by 18.6% in the fourth quarter. Bridgewater Associates LP now owns 6,466 shares of the medical research company's stock worth $1,032,000 after buying an additional 1,013 shares during the last quarter. Guggenheim Capital LLC boosted its holdings in shares of Agilent Technologies by 24.2% in the fourth quarter. Guggenheim Capital LLC now owns 36,056 shares of the medical research company's stock worth $5,756,000 after acquiring an additional 7,035 shares during the period. Caisse DE Depot ET Placement DU Quebec boosted its holdings in shares of Agilent Technologies by 23.1% in the fourth quarter. Caisse DE Depot ET Placement DU Quebec now owns 165,447 shares of the medical research company's stock worth $26,414,000 after acquiring an additional 31,000 shares during the period. Adage Capital Partners GP L.L.C. boosted its holdings in shares of Agilent Technologies by 22.1% in the fourth quarter. Adage Capital Partners GP L.L.C. now owns 322,594 shares of the medical research company's stock worth $51,502,000 after acquiring an additional 58,311 shares during the period. Finally, Camden Capital LLC bought a new position in shares of Agilent Technologies in the fourth quarter worth $231,000.

其他一些机构投资者和对冲基金最近也调整了对该公司的持股。Bridgewater Associates LP在第四季度将其在安捷伦技术公司的头寸增加了18.6%。Bridgewater Associates LP现在拥有这家医疗研究公司6466股股票,价值103.2万美元,在上个季度又购买了1013股。古根海姆资本有限责任公司在第四季度增持了24.2%的安捷伦技术公司的股票。古根海姆资本有限责任公司目前持有这家医学研究公司36,056股股票,价值5756,000美元,在此期间又购买了7,035股。Caisse DE Depot et Placement DU魁北克在第四季度增持了23.1%的安捷伦科技股票。魁北克Caisse DE Depot et Placement DU现在拥有这家医学研究公司165,447股股票,价值26,414,000美元,在此期间又购买了31,000股。Adage Capital Partners GP L.L.C.在第四季度将其持有的安捷伦科技股份增加了22.1%。Adage Capital Partners GP L.L.C.在此期间额外收购了58,311股,现在拥有这家医学研究公司322,594股股票,价值51,502,000美元。最后,Camden Capital LLC在第四季度购买了价值231,000美元的安捷伦技术公司的新股票头寸。

Get
到达
Agilent Technologies
安捷伦科技
alerts:
警报:

Wall Street Analysts Forecast Growth

华尔街分析师预测经济增长

A number of equities analysts have recently commented on the company. Robert W. Baird raised their price target on Agilent Technologies from $155.00 to $160.00 and gave the stock an "outperform" rating in a report on Wednesday, August 17th. Credit Suisse Group assumed coverage on Agilent Technologies in a report on Wednesday, August 24th. They issued an "outperform" rating and a $165.00 price target for the company. Evercore ISI raised their price target on Agilent Technologies to $145.00 in a report on Monday, August 22nd. Bank of America raised their price target on Agilent Technologies from $148.00 to $155.00 and gave the stock a "buy" rating in a report on Wednesday, August 17th. Finally, UBS Group assumed coverage on Agilent Technologies in a research note on Wednesday, July 20th. They set a "buy" rating and a $139.00 price objective for the company. Four analysts have rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, Agilent Technologies currently has an average rating of "Moderate Buy" and a consensus price target of $151.31.

一些股票分析师最近对该公司发表了评论。罗伯特·W·贝尔德将安捷伦科技公司的目标价从155.00美元上调至160.00美元,并在8月17日周三的一份报告中给出了该股“跑赢大盘”的评级。瑞士信贷集团在8月24日星期三的一份报告中对安捷伦科技进行了报道。他们给出了“跑赢大盘”的评级和165.00美元的目标价。在8月22日周一的一份报告中,Evercore ISI将安捷伦科技的目标价上调至145.00美元。美国银行在8月17日周三的一份报告中将安捷伦科技的目标价从148.00美元上调至155.00美元,并给予该股“买入”评级。最后,瑞银集团在7月20日星期三的一份研究报告中对安捷伦科技进行了报道。他们为该公司设定了“买入”评级和139.00美元的目标价。四位分析师对该股的评级为持有,九位分析师发布了买入评级,一位分析师对该公司股票给予了强烈的买入评级。根据MarketBeat的数据,安捷伦科技目前的平均评级为“适度买入”,共识目标价为151.31美元。

Agilent Technologies Trading Down 1.0 %

安捷伦科技股价下跌1.0%

NYSE A opened at $121.55 on Friday. The stock's 50-day simple moving average is $130.78 and its two-hundred day simple moving average is $126.57. Agilent Technologies, Inc. has a twelve month low of $112.52 and a twelve month high of $165.68. The company has a quick ratio of 1.41, a current ratio of 1.94 and a debt-to-equity ratio of 0.54. The company has a market capitalization of $35.98 billion, a price-to-earnings ratio of 27.69, a PEG ratio of 2.42 and a beta of 1.06.
纽约证交所A股上周五开盘报121.55美元。该股的50日简单移动均线切入位在130.78美元,200日简单移动均线切入位在126.57美元。安捷伦科技公司股价跌至112.52美元的12个月低点和165.68美元的12个月高点。该公司的速动比率为1.41,流动比率为1.94,债务权益比率为0.54。该公司市值为359.8亿美元,市盈率为27.69倍,聚乙二醇率为2.42倍,贝塔系数为1.06。

Agilent Technologies (NYSE:A – Get Rating) last released its quarterly earnings results on Tuesday, August 16th. The medical research company reported $1.34 earnings per share for the quarter, beating analysts' consensus estimates of $1.20 by $0.14. Agilent Technologies had a return on equity of 28.46% and a net margin of 19.94%. The business had revenue of $1.72 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter last year, the business posted $1.10 earnings per share. The company's revenue for the quarter was up 8.3% on a year-over-year basis. Research analysts forecast that Agilent Technologies, Inc. will post 5.07 EPS for the current fiscal year.

安捷伦科技公司(纽约证券交易所代码:A-GET评级)最近一次发布季度收益报告是在8月16日,星期二。这家医学研究公司公布,该季度每股收益为1.34美元,比分析师普遍预期的1.20美元高出0.14美元。安捷伦科技的股本回报率为28.46%,净利润率为19.94%。该业务本季度营收为17.2亿美元,而市场普遍预期为16.4亿美元。去年同一季度,该公司公布的每股收益为1.10美元。该公司当季营收同比增长8.3%。研究分析师预测,安捷伦技术公司本财年每股收益将达到5.07欧元。

Agilent Technologies Dividend Announcement

安捷伦技术公司宣布分红

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 26th. Stockholders of record on Tuesday, October 4th will be issued a $0.21 dividend. The ex-dividend date is Monday, October 3rd. This represents a $0.84 annualized dividend and a dividend yield of 0.69%. Agilent Technologies's dividend payout ratio is currently 19.13%.

该公司最近还披露了季度股息,将于10月26日(星期三)支付。10月4日(星期二)登记在册的股东将获得0.21美元的股息。除股息日期为10月3日星期一。这意味着年化股息为0.84美元,股息收益率为0.69%。安捷伦科技目前的派息比率为19.13%。

Insider Transactions at Agilent Technologies

安捷伦技术公司的内幕交易

In other news, VP Padraig Mcdonnell sold 2,103 shares of Agilent Technologies stock in a transaction dated Wednesday, September 28th. The stock was sold at an average price of $122.89, for a total value of $258,437.67. Following the transaction, the vice president now owns 13,217 shares in the company, valued at $1,624,237.13. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

在其他新闻方面,副总裁帕德雷格·麦克唐奈在9月28日星期三的交易中出售了2,103股安捷伦技术公司的股票。这只股票的平均售价为122.89美元,总价值为258,437.67美元。交易完成后,副总经理总裁现在拥有该公司13,217股,价值1,624,237.13美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,该文件可以通过这个环节.

About Agilent Technologies

关于安捷伦技术公司

(Get Rating)

(获取评级)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

安捷伦技术公司为全球生命科学、诊断和应用化学品市场提供以应用为重点的解决方案。生命科学和应用市场部门提供液相色谱系统和部件;液相色谱质谱系统;气相色谱系统和部件;气相色谱-质谱仪系统;电感耦合等离子体质谱仪器;原子吸收仪器;微波等离子体原子发射光谱仪;电感耦合等离子光谱仪器;拉曼光谱;细胞分析平板分析;流式细胞仪;实时细胞分析仪;细胞成像系统;微孔板阅读器;实验室软件;信息管理和分析;实验室自动化和机器人系统;溶解测试;真空泵;以及测量技术。

Read More

阅读更多内容

  • Get a free copy of the StockNews.com research report on Agilent Technologies (A)
  • EV Battery Maker Freyr Set For Major Global Expansion
  • MarketBeat: Week in Review 9/26 – 9/30
  • This Is A Memorable Time To Buy Into Micron Technology
  • How Does Keurig Dr Pepper Compare To Larger Rivals Coke & Pepsi?
  • Let Paychex Stock Work Hard For You
  • 免费获取StockNews.com关于安捷伦技术的研究报告(A)
  • 电动汽车电池制造商Freyr将在全球大举扩张
  • MarketBeat:回顾一周9/26-9/30
  • 这是买入美光科技的难忘时刻
  • Keurig Dr Pepper与规模更大的竞争对手可口可乐(Coke&Pepsi)相比如何?
  • 让Paychex股票为您努力工作

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Get Rating).

想看看其他对冲基金持有A的什么吗?访问HoldingsChannel.com获取安捷伦技术公司(纽约证券交易所代码:A-GET评级)的最新13F文件和内幕交易。

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

接受安捷伦科技日报的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对安捷伦科技和相关公司的最新新闻和分析师评级的每日简明摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发